Table 1.
Study participant details, treatment histories and identified proviral genome status.
PID | Age ART Initiated (Months) | ART Regimen | Time on ART (Years) | No. of Proviral Genomes Sequenced with ONT | |
---|---|---|---|---|---|
Identified as Intact | Identified as Defective | ||||
333716 | 2.3 | AZT/3TC/LPV/r | 8.55 | 0 | 1 |
339606 | 8.5 | AZT/3TC/LPV/r | 7.93 | 2 | 1 |
339266 | 9.23 | AZT/3TC/LPV/r | 8.2 | 4 | 0 |
340116 | 9.32 | AZT/3TC/LPV/r | 8.83 | 1 | 0 |
Therapy included Zidovudine (AZT), lamivudine (3TC) and lopinavir with low dose ritonavir (LPV/r).